Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AbbVie Inc. | 386,479 | reported | 31 Mar 2025 | tx 348+7,074,089−5,792,420 |
| ABBOTT LABORATORIES | 185,575 | reported | 06 Apr 2012 | tx 228+3,234,893−3,093,885 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Mar 2025 | GIFT | AbbVie Inc. | 2,450 | 0.00 USD | |
| 03 Mar 2025 | SALE | AbbVie Inc. | 6,168 | 210.53 USD | |
| 28 Feb 2025 | SALE | AbbVie Inc. | 92,460 | 205.11 USD | |
| 28 Feb 2025 | TAX_WITHHOLDING | AbbVie Inc. | 73,209 | 205.02 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 33,208 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 30,298 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 27,386 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 80,945 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 65,104 | 0.00 USD | deriv |
| 30 Sept 2024 | GIFT | AbbVie Inc. | 36,698 | 0.00 USD | |
| 30 Sept 2024 | GIFT | AbbVie Inc. | 15,729 | 0.00 USD | |
| 30 Sept 2024 | GIFT | AbbVie Inc. | 5,243 | 0.00 USD | |
| 05 Aug 2024 | SALE | AbbVie Inc. | 66,500 | 186.52 USD | |
| 17 Jul 2024 | EXERCISE | AbbVie Inc. | 119,418 | 79.02 USD | |
| 17 Jul 2024 | EXERCISE | AbbVie Inc. | 76,377 | 93.50 USD | |
| 17 Jul 2024 | EXERCISE | AbbVie Inc. | 87,050 | 61.36 USD | |
| 17 Jul 2024 | SALE | AbbVie Inc. | 282,845 | 175.00 USD | |
| 17 Jul 2024 | EXERCISE | AbbVie Inc. | 76,377 | 0.00 USD | deriv |
| 17 Jul 2024 | EXERCISE | AbbVie Inc. | 87,050 | 0.00 USD | deriv |
| 17 Jul 2024 | EXERCISE | AbbVie Inc. | 119,418 | 0.00 USD | deriv |
| 28 Jun 2024 | GIFT | AbbVie Inc. | 6,000 | 0.00 USD | |
| 28 Feb 2024 | TAX_WITHHOLDING | AbbVie Inc. | 110,249 | 178.99 USD | |
| 28 Feb 2024 | SALE | AbbVie Inc. | 138,616 | 177.27 USD | |
| 27 Feb 2024 | GIFT | AbbVie Inc. | 1,670 | 0.00 USD | |
| 27 Feb 2024 | GIFT | AbbVie Inc. | 2,525 | 0.00 USD |